Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Placebo Controlled Mntnance Ixazomib after Allogeneic HSCT for High Risk Multiple Myeloma

Protocol: BMT-CTN1302

Full Title

Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma

Multiple Myeloma